A Stock Analysis: Buy, Sell, or Hold?
A - Agilent Technologies Inc.
$130.69
-2.70 (-2.02%)
▼
5d:
-3.56%
30d:
-3.23%
90d:
+14.1%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 26, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.2/10
Get Alerted When A Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: A shows positive signals but monitor for confirmation. Market pricing in 0.3% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: A shows positive signals but monitor for confirmation. Market pricing in 0.3% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$177.85
Based on 6.6% avg growth
INTRINSIC VALUE TODAY
$110.43
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: A is currently trading at $130.69, which is considered fair relative to its 30-day fair value range of $125.42 to $136.77. The stock's valuation (Forward PE: 19.8) is in line with its historical norms (19.6). At these levels, the market is pricing in 0.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, A is in a uptrend. Immediate support is located at $125.17, while resistance sits at $138.62.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $160.33 (+22.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, A is in a uptrend. Immediate support is located at $125.17, while resistance sits at $138.62.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $160.33 (+22.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$125.42 -
$136.77
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.3%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.7% below Wall St target ($160.33)
- NEUTRAL: Market pricing in 0.3% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$125.42 -
$136.77
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$125.17
Resistance Level
$138.63
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.76
Wall Street Target
$160.33
(+22.7%)
Revenue Growth (YoY)
10.0%
Earnings Growth (YoY)
60.0%
Profit Margin
19.6%
Valuation Premium vs History
+0.3% premium
PE vs Historical
19.8 vs 19.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.3%
(market-implied from PE analysis)
1-Year Target
$131.08
(+0%)
2-Year Target
$131.48
(+1%)
3-Year Target
$131.87
(+1%)
3-Yr Target (if PE normalizes)
(PE: 20→20)
PE COMPRESSION
$130.77
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 9.1%)
$187.15
(+43%)
Base:
(SPY PE: 19.8, Growth: 9.1%)
$169.83
(+30%)
Bear:
(PE: 16.8, Growth: 9.1%)
$144.35
(+11%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 26.79 | Current EPS (TTM): $4.98
Bull Case
$194.82
(+49%)
Analyst growth 32.8%, PE expands to 29.5
Base Case
$177.11
(+36%)
Market implied 32.8%, PE stable at 26.8
Bear Case
$90.71
(-31%)
Severe decline -20.0%, PE contracts to 22.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 03, 2026 9:20 PM ET
Data refreshes hourly during market hours. Next update: 10:20 PM
Data refreshes hourly during market hours. Next update: 10:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is A showing a specific setup today?
Insider Activity (6 Months)
1
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
Ro Khanna
BUY
2026-03-10
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 64 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$144 | 61 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 54 HOLD |
Advanced A Option Strategies
Professional options setups generated by AI based on today's A price and gamma walls.
